<DOC>
	<DOC>NCT01190007</DOC>
	<brief_summary>The primary objective is to investigate the safety of Caduet (2.5 mg/5 mg, 2.5 mg/10 mg, 5 mg/5 mg or 5 mg/10 mg as dose of Amlodipine/Atorvastatin) during 52 weeks treatment period in Japanese patients with both of hypertension and hypercholesterolemia, or with both angina pectoris and hypercholesterolemia.</brief_summary>
	<brief_title>Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Amlodipine, atorvastatin drug combination</mesh_term>
	<criteria>Subject with both hypertension and hypercholesterolemia must meet the following (1), and the following (2) or (3): (1) Subjects who take Amlodipine 2.5mg/day or 5mg/day at least 28 days before Week 2, and Subjects with well controlled BP value (BP value &lt; 140/90mmHg at Week 0) (2) Subjects who take Atorvastatine 5mg/day or 10mg/day at least 28days before Week 2 (3) Statinnaïve patient, defined as receiving no statin therapy for more than 3 months during the previous 12 months, with LDLC ≥ 160 mg/dL, LDLC &lt; 250 mg/dL, and TG &lt; 400 mg/dL at Week 2 Subject with both angina pectoris and hypercholesterolemia must meet the following (1), and the following (2) or (3): (1) Subjects who take Amlodipine 2.5mg/day or 5mg/day at least 28 days before Week 2, and who meet the following criteria; Subjects with well controlled BP value (BP value &lt; 140/90mmHg at Week 0), and subjects with clinically stable of angina pectoris (2) Subjects who take Atorvastatine 5mg/day or 10mg/day at least 28days before Week 2 (3) Statinnaïve patient, defined as receiving no statin therapy for more than 3 months during the previous 12 months, with LDLC ≥ 160 mg/dL, LDLC &lt; 250 mg/dL, and TG &lt; 400 mg/dL at Week 2 Subjects who need three or more multiantihypertensive therapies to achieve the target BP level or uncontrolled status of hypertension at Week 0 (V1); the target BP level is defined as systolic blood pressure &lt; 140mmHg and diastolic blood pressure &lt; 90 mmHg. Uncontrolled or uncontrollable status of hypercholesterolemia at Week 2; A LDLC ≥ 160 mg/dL even though Atorvastatine 10 mg has administrated</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>